Tag: Non absorbable antibiotic

An estimated 40% of cirrhotic patients experience hepatic encephalopathy (HE), a severe neuropsychiatric complication. The non-absorbable antibiotic rifaximin helps with hepatic encephalopathy by targeting the gut-liver-brain axis to reduce toxic byproducts that affect brain function.

Clinical studies show that the time it takes for Xifaxan (rifaximin) to work varies significantly depending on the medical condition being treated. For instance, symptom improvement for traveler's diarrhea may occur within days, while those with irritable bowel syndrome with diarrhea (IBS-D) may see relief weeks after completing their treatment course.